General CEU: MFP Implications on Provider Reimbursement

MFP Implications on Provider Reimbursement is the kind of topic that looks straightforward until it collides with the speed, ambiguity, and competing demands of clinical documentation, payer communication, supervision records, and leadership review. In MFP Implications on Provider Reimbursement, for this course, the practical stakes show up in service continuity, accurate reporting, and defensible clinical decisions, not in abstract discussion alone.

Provider: BehaviorLive — via AVBCC

Take This Course →

Course Description

While MFP negotiation aims to reduce drug cost exposure across the healthcare ecosystem, the downstream implications are likely to be significant, particularly with regard to provider reimbursement. This discussion will explore the known and not-so-well known implications to provider reimbursement, what behaviors may occur, and what that means moving forward: MFP Economics: By the numbers, how will MFP impact provider reimbursement vs. today, Implications: What does that mean for providers, and what is the likely implications to drug procurement, reimbursement & care delivery?, Near- and Long-Term: How will providers respond near- (2026, Part D) and long- (2028+, Part B) term?

What You'll Learn

1. Describe how MFP negotiation impacts provider reimbursement across Medicare Parts B and D.
2. Identify the near-term and long-term implications of MFP on drug procurement and care delivery.
3. Evaluate how providers are likely to respond to changes in reimbursement resulting from MFP implementation.

CEU Credits Earned

Certification Body	Credits	Type
BACB	1	General

About the Instructor